BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21488588)

  • 1. Pemetrexed and maintenance therapy for non-small cell lung cancer.
    Prescrire Int; 2011 Feb; 20(113):39. PubMed ID: 21488588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of use of pemetrexed in non-small cell lung cancer].
    Villanueva-Herraiz S; Ortega-García MP; Camps-Herrero C; Blasco-Segura P
    Farm Hosp; 2010; 34(4):194-203. PubMed ID: 20594885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].
    Pérol M
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S14-7. PubMed ID: 16273004
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
    Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
    Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety of pemetrexed mono-therapy in elderly patients with non-small cell lung cancer].
    Konishi A; Kitada N; Nanjo S; Tanaka S; Tomii K; Katakami N; Hashida T
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1507-10. PubMed ID: 23064061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemetrexed in advanced non-small-cell lung cancer.
    Fuld AD; Dragnev KH; Rigas JR
    Expert Opin Pharmacother; 2010 Jun; 11(8):1387-402. PubMed ID: 20446853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed in advanced non-small cell lung cancer.
    Gridelli C; Maione P; Rossi A; Bareschino MA; Schettino C; Sacco PC; Zeppa R
    Expert Opin Drug Saf; 2011 Mar; 10(2):311-7. PubMed ID: 21261558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update of pemetrexed in thoracic oncology].
    Brechot JM; Morère JF
    Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed for the treatment of non-small-cell lung cancer.
    Manegold C; Schmid-Bindert G; Pilz LR
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemetrexed-induced lung toxicity: a case report.
    Breuer S; Nechushtan H
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):76-7. PubMed ID: 21924594
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of a promising new agent--pemetrexed disodium.
    Paz-Ares L; Bezares S; Tabernero JM; Castellanos D; Cortes-Funes H
    Cancer; 2003 Apr; 97(8 Suppl):2056-63. PubMed ID: 12673697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
    Bearz A; Garassino I; Cavina R; Favaretto A; Boccalon M; Talamini R; Berretta M; Spazzapan S; Simonelli C; Santoro A; Tirelli U
    Lung Cancer; 2008 May; 60(2):240-5. PubMed ID: 18022729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management and maintenance of pemetrexed monotherapy regimen - initial experience of pretreated non-small cell lung cancer].
    Takase M; Maruoka H; Ametani F; Takahashi M; Shibata K
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):563-5. PubMed ID: 22504678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemetrexed induced aseptic meningitis.
    Shah BK; O'Keefe S
    Acta Oncol; 2012 Mar; 51(3):399-400. PubMed ID: 21936754
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of pemetrexed-induced acute lung injury in non-small cell lung cancer.
    Kim HO; Lee SY; Shim JJ; Kang KH; Shin BK
    J Thorac Oncol; 2010 Mar; 5(3):401-2. PubMed ID: 20186027
    [No Abstract]   [Full Text] [Related]  

  • 17. Interstitial pneumonitis after treatment with pemetrexed: a rare event?
    Hochstrasser A; Benz G; Joerger M; Templeton A; Brutsche M; Früh M
    Chemotherapy; 2012; 58(1):84-8. PubMed ID: 22377772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial.
    Gridelli C; Di Maio M
    Expert Opin Pharmacother; 2010 Feb; 11(2):321-4. PubMed ID: 20053140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy and safety of pemetrexed as monotherapy for Chinese patients with advanced non-small cell lung cancer].
    Zhong W; Zhao J; Zhang XT; Zhang L; Wang MZ; Li LY
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):671-4. PubMed ID: 20979786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemetrexed-induced hyperpigmentation of the skin.
    Schallier D; Decoster L; de Greve J
    Anticancer Res; 2011 May; 31(5):1753-5. PubMed ID: 21617235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.